Thermo Fisher Scientific Chief Executive Marc N. Casper said Tuesday that he had expected "moderating growth" in 2023 as the COVID-19 pandemic wound down and customers became more cautious.

Marc Casper is chairman, president, and CEO of Thermo Fisher Scientific, the world leader in serving science. He leads more than 100,000 colleagues globally to fulfill the company’s mission of ...

said CEO Marc N. Casper at the JP Morgan Healthcare conference on January 14, 2025. In a presentation at the JP Morgan Healthcare Conference 2025, taking place January 13-16 in San Francisco ...

NEW YORK - Thermo Fisher Scientific Inc. (NYSE:TMO) reported fourth-quarter earnings and revenue that exceeded analyst expectations, sending shares up 1.50% in early trading.

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 performance.